Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

56.22
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
26.26
Today|||52-Week Range
57.57
+104.96%
Year-to-Date
10 Biotech Stocks to Watch in 2018
Nov 22 / TheStreet.com - Paid Partner Content
Is the Options Market Predicting a Spike in Sarepta Therapeutics (SRPT) Stock?
Nov 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close56.22
Today’s open56.09
Day’s range55.60 - 56.50
Volume1,363,850
Average volume (3 months)2,607,333
Market cap$3.6B
Dividend yield--
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)-5.58%
Earnings growth (this year)+85.96%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+332.64%
P/E ratioNM
Price/Sales246.40
Price/Book9.08

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...0.000.00%
MDCOMedicines Co0.000.00%
GWPHGW Pharmaceuticals P...0.000.00%
PBHPrestige Brands Hold...0.000.00%
Data as of 4:02pm ET, 11/22/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$5.4M
Annual profit (last year)-$267.3M
Net profit margin-4,930.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas S. Ingram
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts